154 related articles for article (PubMed ID: 2997237)
1. Interactions between cyclic AMP- and phorbol ester-dependent phosphorylation systems in S49 mouse lymphoma cells.
Kiss Z; Steinberg RA
J Cell Physiol; 1985 Nov; 125(2):200-6. PubMed ID: 2997237
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester-mediated protein phosphorylations in S49 mouse lymphoma cells.
Kiss Z; Steinberg RA
Cancer Res; 1985 Jun; 45(6):2732-40. PubMed ID: 3157448
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of regulatory subunit of type I cyclic AMP-dependent protein kinase: biphasic effects of cyclic AMP in intact S49 mouse lymphoma cells.
Russell JL; Steinberg RA
J Cell Physiol; 1987 Feb; 130(2):207-13. PubMed ID: 3029147
[TBL] [Abstract][Full Text] [Related]
4. Genetic evidence that a phorbol ester tumor promoter stimulates ornithine decarboxylase activity by a pathway that is independent of cyclic AMP-dependent protein kinases in CHO cells.
Lichti U; Gottesman MM
J Cell Physiol; 1982 Dec; 113(3):433-9. PubMed ID: 6294128
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester-induced augmentation and inhibition of epinephrine-stimulated adenylate cyclase in S49 lymphoma cells.
Johnson JA; Goka TJ; Clark RB
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):199-215. PubMed ID: 3020100
[TBL] [Abstract][Full Text] [Related]
6. Activation of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in H35 hepatoma and Chinese hamster ovary cells by a phorbol ester tumor promoter.
Byus CV; Trevillyan JM; Cavit LJ; Fletcher WH
Cancer Res; 1983 Jul; 43(7):3321-6. PubMed ID: 6303580
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation.
Yoshimasa T; Sibley DR; Bouvier M; Lefkowitz RJ; Caron MG
Nature; 1987 May 7-13; 327(6117):67-70. PubMed ID: 3033513
[TBL] [Abstract][Full Text] [Related]
8. Second-site mutations in cyclic AMP-sensitive revertants of a Ka mutant of S49 mouse lymphoma cells reduce the affinity of regulatory subunit of cyclic AMP-dependent protein kinase for catalytic subunit.
Cauthron RD; Gorman KB; Symcox MM; Steinberg RA
J Cell Physiol; 1995 Nov; 165(2):376-85. PubMed ID: 7593216
[TBL] [Abstract][Full Text] [Related]
9. Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
Thomas JM; Hoffman BB
Mol Pharmacol; 1989 Jan; 35(1):116-24. PubMed ID: 2563303
[TBL] [Abstract][Full Text] [Related]
10. Effect of epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate on the phosphorylation of soluble acidic proteins in A431 epidermoid carcinoma cells.
Sahai A; Feuerstein N; Cooper HL; Salomon DS
Cancer Res; 1986 Aug; 46(8):4143-50. PubMed ID: 3015383
[TBL] [Abstract][Full Text] [Related]
11. Differences in the mode of action of 1-oleoyl-2-acetyl-glycerol and phorbol ester in platelet activation.
Ashby B; Kowalska MA; Wernick E; Rigmaiden M; Daniel JL; Smith JB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):473-83. PubMed ID: 2999204
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of adenylate cyclase activity in S49 lymphoma cells by phorbol esters. Putative effect of C kinase on alpha s-GTP-catalytic subunit interaction.
Bell JD; Buxton IL; Brunton LL
J Biol Chem; 1985 Mar; 260(5):2625-8. PubMed ID: 2857714
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells.
Beazely MA; Alan JK; Watts VJ
Mol Pharmacol; 2005 Jan; 67(1):250-9. PubMed ID: 15470083
[TBL] [Abstract][Full Text] [Related]
14. Effect of retinoic acid on phorbol ester-stimulated differentiation and protein kinase C-dependent phosphorylation in the U937 human monoblastoid cell.
Ways DK; Dodd RC; Bennett TE; Hooker JL; Earp HS
Cancer Res; 1988 Oct; 48(20):5779-87. PubMed ID: 3048649
[TBL] [Abstract][Full Text] [Related]
15. Adenylyl cyclase-cAMP system inhibits thrombin-induced HSP27 in vascular smooth muscle cells.
Hirade K; Tanabe K; Niwa M; Ishisaki A; Nakajima K; Nakamura M; Sugiyama T; Katagiri Y; Kato K; Kozawa O
J Cell Biochem; 2005 Feb; 94(3):573-84. PubMed ID: 15543559
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the dominance of mutations in cAMP-binding sites of murine type I cAMP-dependent protein kinase in activation of kinase from heterozygous mutant lymphoma cells.
Shuntoh H; Steinberg RA
J Cell Physiol; 1991 Jan; 146(1):86-93. PubMed ID: 1846638
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
Albert DA; Nodzenski E; Yim G; Kowalski J
J Cell Physiol; 1990 May; 143(2):251-6. PubMed ID: 2159014
[TBL] [Abstract][Full Text] [Related]
19. Multiple effects of phorbol esters on hormone-sensitive adenylate cyclase activity in S49 lymphoma cells.
Bell JD; Brunton LL
Am J Physiol; 1987 Jun; 252(6 Pt 1):E783-9. PubMed ID: 3035937
[TBL] [Abstract][Full Text] [Related]
20. Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C.
Lembo PM; Albert PR
Mol Pharmacol; 1995 Dec; 48(6):1024-9. PubMed ID: 8848001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
